PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+15.33%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$112M
AUM Growth
+$112M
(-3.9%)
Cap. Flow
-$29.7M
Cap. Flow
% of AUM
-26.58%
Top 10 Holdings %
Top 10 Hldgs %
35.03%
Holding
122
New
10
Increased
12
Reduced
75
Closed
10
Top Buys
| 1 |
ASPU
ASPEN GROUP, INC.
ASPU
|
$1.24M |
| 2 |
QUMU
Qumu Corp.
QUMU
|
$1.11M |
| 3 |
AKTS
AKOUSTIS TECHNOLOGIES, INC.
AKTS
|
$777K |
| 4 |
BIOL
Biolase, Inc.
BIOL
|
$729K |
| 5 |
FlexShopper
FPAY
|
$580K |
Top Sells
| 1 |
QuickLogic
QUIK
|
$7.23M |
| 2 |
CGRN
Capstone Green Energy Corporation Common Stock
CGRN
|
$6.33M |
| 3 |
Venus Concept
VERO
|
$1.71M |
| 4 |
Cantaloupe
CTLP
|
$1.71M |
| 5 |
TEUM
Pareteum Corporation
TEUM
|
$1.52M |
Sector Composition
| 1 | Healthcare | 63.13% |
| 2 | Technology | 12.23% |
| 3 | Industrials | 6.62% |
| 4 | Communication Services | 6.04% |
| 5 | Consumer Staples | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NeoGenomics
NEO
$1.13B
| $7.39M | 6.62% | 252,500 -9,800 | -4% | -$287K |
|
2
Vericel Corp
VCEL
$1.83B
| $6.15M | 5.52% | 353,547 -45,450 | -11% | -$791K |
|
3
Axogen
AXGN
$743M
| $5.31M | 4.76% | 296,790 -22,985 | -7% | -$411K |
|
4
Veracyte
VCYT
$2.39B
| $3.7M | 3.32% | 132,630 -15,500 | -10% | -$433K |
|
5
Idexx Laboratories
IDXX
$51.8B
| $2.96M | 2.66% | 11,350 | – | – |
|
|
6
FlexShopper
FPAY
$17M
| $2.87M | 2.57% | 1,132,400 +229,300 | +25% | +$580K |
|
|
CSII
7
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.86M | 2.56% | 58,783 -9,983 | -15% | -$485K |
|
8
Natera
NTRA
$23.1B
| $2.76M | 2.47% | 81,900 -27,000 | -25% | -$910K |
|
9
Microsoft
MSFT
$3.77T
| $2.58M | 2.32% | 16,385 | – | – |
|
10
Magnite
MGNI
$3.7B
| $2.5M | 2.24% | 305,733 -31,650 | -9% | -$258K |
|
11
Abbott
ABT
$231B
| $2.46M | 2.2% | 28,293 -6,318 | -18% | -$549K |
|
12
LeMaitre Vascular
LMAT
$2.16B
| $2.23M | 2% | 62,030 +900 | +1% | +$32.4K |
|
13
Exagen
XGN
$217M
| $2.18M | 1.96% | 85,850 -1,600 | -2% | -$40.6K |
|
14
Pfizer
PFE
$141B
| $2.04M | 1.83% | 52,140 -6,300 | -11% | -$247K |
|
15
Eli Lilly
LLY
$657B
| $1.85M | 1.66% | 14,100 -4,410 | -24% | -$580K |
|
16
Rockwell Medical
RMTI
$58.9M
| $1.81M | 1.63% | 743,400 -92,600 | -11% | -$226K |
|
17
Digital Turbine
APPS
$455M
| $1.8M | 1.62% | 252,800 -7,500 | -3% | -$53.5K |
|
|
HTGM
18
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $1.77M | 1.59% | 2,527,000 +173,847 | +7% | +$122K |
|
19
OptimizeRx
OPRX
$335M
| $1.77M | 1.59% | 172,172 -13,651 | -7% | -$140K |
|
20
CareDx
CDNA
$727M
| $1.75M | 1.57% | 81,133 -29,200 | -26% | -$630K |
|
21
CryoPort
CYRX
$444M
| $1.63M | 1.46% | 99,100 -3,500 | -3% | -$57.6K |
|
|
AKTS
22
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $1.63M | 1.46% | 203,500 +97,150 | +91% | +$777K |
|
23
AtriCure
ATRC
$1.84B
| $1.58M | 1.42% | 48,700 -6,300 | -11% | -$205K |
|
24
AT&T
T
$209B
| $1.57M | 1.4% | 40,062 -4,000 | -9% | -$156K |
|
25
Target
TGT
$43.6B
| $1.52M | 1.36% | 11,829 -2,811 | -19% | -$360K |
|